Landscapes / Companies
SIGA Technologies not checked
FollowEvery new trial, moved date and filing, and a Monday email
Drugs
1
in active trials · 4 in all
Trials
1 active
8 since 2021
Drugs1
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
Orthopoxvirus VP37 envelope wrapping protein inhibitor |
Approved | 1 Jan 2027Phase 2 trial completes | |||
| Next date | 1 Jan 2027 · Phase 2 trial completes | ||||
| Also tested for | Smallpox | ||||
| Open drug page | |||||
About
- No active trial
- Lanthanum Carbonate Chewable, sucroferric oxyhydroxide chewable, Tpoxx
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 Industry-sponsored drug trials since 2021